Dec 10, 2024 / 10:00AM GMT
Operator
Good morning and welcome to the Skin Biotherapeutics PC Investor presentation. (Operator Instructions) Before we begin, I'd like to submit the following poll and I now like to hand over to Stuart Ashman CEO. Good morning, sir.
Stuart Ashman - SkinBioTherapeutics PLC - Chief Executive Officer, Executive Director
Good morning. Thank you. Thank you all for your time this morning. This is our, our second investor meets in less than a couple of weeks. So, yeah, we're, we're breaking the mold a little bit here. This is our presentation where we will go through the full year results that ended 30th of June 2024. We'll obviously talk in reference to some of the things that happened post year end. And we'll try to get this done in an orderly manner. I have seen a number of questions submitted and we will do as always our utmost to get through as many of those as is humanly possible.
So, on the agenda today, we have operational financial highlights and we'll go through the strategy for for the past year and the coming year. We'll do an operational review of our
Full Year 2024 SkinBioTherapeutics PLC Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot